P. Gross

发表

Vaptans are not the mainstay of treatment in hyponatremia: perhaps not yet.

G. Decaux, P. Gross, A. Wagner, 2011, Kidney international.

Lithium induced polyuria and renal vasopressin receptor density

J. Hensen, P. Gross, M. Haenelt, 1996 .

Evidence in vivo showing increase of baseline nitric oxide generation and impairment of endothelium-dependent vasodilation in normotensive patients on chronic hemodialysis.

U. Range, J. Passauer, E. Büssemaker, 2000, Journal of the American Society of Nephrology : JASN.

Pathogenesis of clinical hyponatremia: observations of vasopressin and fluid intake in 100 hyponatremic medical patients

A. Schömig, E. Ritz, W. Rascher, 1987, European journal of clinical investigation.

Dialysis hypotension: do we see light at the end of the tunnel?

J. Passauer, P. Gross, E. Büssemaker, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Con: Tolvaptan for autosomal dominant polycystic kidney disease-do we know all the answers?

A. Paliege, P. Gross, H. Schirutschke, 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Polycystic kidney disease: will it become treatable?

P. Gross, 2008, Polskie Archiwum Medycyny Wewnetrznej.

Thiazides: do they kill?

P. Gross, C. Palm, 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Creating a Fistula That Works: Is It an Art or Is It Science?

P. Gross, 2005, Nephron Clinical Practice.

Role of diuretics, hormonal derangements, and clinical setting of hyponatremia in medical patients

A. Schömig, E. Ritz, W. Rascher, 1988, Klinische Wochenschrift.

[Kidney function in heart failure].

A. Schömig, M. Ketteler, J. Hensen, 1989, Klinische Wochenschrift.

Treatment of severe hyponatremia: conventional and novel aspects.

P. Gross, J. Henschkowski, D. Reimann, 2001, Journal of the American Society of Nephrology : JASN.

Successful long-term treatment of hyponatremia in syndrome of inappropriate antidiuretic hormone secretion with satavaptan (SR121463B), an orally active nonpeptide vasopressin V2-receptor antagonist.

D. Annane, H. Heshmati, G. Decaux, 2006, Clinical journal of the American Society of Nephrology : CJASN.

Hyponatremia now--a goldmine or a dead end?

P. Gross, 2012, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

Treatment of hyponatremia.

P. Gross, 2008, Internal medicine.

Internalization of V2-vasopressin receptors in LLC-PK1-cells: evidence for receptor-mediated endocytosis.

B. Hocher, H. Merker, J. Hensen, 1992, Biochemical and biophysical research communications.

Successful Long-Term Treatment of Hyponatremia in Syndrome of Inappropriate Antidiuretic Hormone Secretion with Satavaptan ( SR 121463 B ) , an Orally Active Nonpeptide Vasopressin V 2-Receptor Antagonist

D. Annane, H. Heshmati, G. Decaux, 2006 .

The vaptans: just landed. But how was the trip?

P. Gross, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Vaptans and the treatment of water-retaining disorders.

P. Gross, F. Quittnat, 2006, Seminars in nephrology.

Hyponatremia: pathophysiology, differential diagnosis and new aspects of treatment.

P. Gross, R. Wehrle, E. Büssemaker, 1996, Clinical nephrology.

The influence of uraemia and haemodialysis on neutrophil phagocytosis and antimicrobial killing.

J. Rost, P. Gross, E. Jacobs, 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.

W. Daniel, D. Werner, P. Gross, 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Natriuretic factors and lithium clearance in patients with the syndrome of inappropriate antidiuretic hormone (SIADH)

E. Ritz, W. Rascher, M. Ketteler, 1989, European journal of clinical investigation.

Natriuretic factors and lithium clearance in patients with the syndrome of inappropriate antidiuretic hormone (SIADH)

W. Rascher, M. Ketteler, P. Gross, 1989 .

Lithium induced polyuria and renal vasopressin receptor density.

J. Hensen, P. Gross, M. Haenelt, 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

MICROALBUMINURIA IN ESSENTIAL HYPERTENSION. AUTHOR'S REPLY

R. Pedrinelli, P. Gross, 1998 .

Gitelman syndrome: when will it turn into Gitelman disease?

P. Gross, 2003, Pediatric Nephrology.

Lixivaptan safely and effectively corrects serum sodium concentrations in hospitalized patients with euvolemic hyponatremia.

W. Abraham, D. Bichet, C. Orlandi, 2012, Kidney international.

[Practical approach to hyponatremia].

T. Benzing, J. Hensen, P. Gross, 2011, Deutsche medizinische Wochenschrift.

[Hypo- and hypernatremia].

P. Gross, A. Wagner, C. Palm, 2011, Deutsche medizinische Wochenschrift.

The vaptans ante portas: a status report.

K. Herbrig, P. Gross, T. Marczewski, 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Atrial Natriuretic Peptide (ANP) in Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)

A. Schömig, M. Ketteler, P. Gross, 1989 .

Vasopressin in Hyponatremia: What Stimuli?

A. Schömig, E. Ritz, W. Rascher, 1986, Journal of cardiovascular pharmacology.

The treatment of hyponatraemia using vasopressin antagonists

P. Gross, C. Palm, 2000, Experimental physiology.

Failure of arginine-vasopressin and other pressor hormones to increase in severe recurrent dialysis hypotension.

E. Ritz, W. Rascher, U. Friess, 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

The role of V2 vasopressin antagonists in hyponatremia.

P Gross, P. Gross, C Palm, 2001, Cardiovascular research.

Successful treatment due to vacuum seal technique of a severe Scedosporium apiospermum skin infection in a renal transplant recipient.

E. Büssemaker, P. Gross, D. Reimann, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Treatment of severe hyponatremia.

J. Verbalis, R. Schrier, G. Decaux, 1998, Kidney international.

Chronic hypokalaemia of adults: Gitelman's syndrome is frequent but classical Bartter's syndrome is rare.

E. Ritz, U. Gladziwa, H. Seyberth, 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Inappropriate secretion of antidiuretic hormone, polydipsia and hypothalamic calcifications

J. Hensen, P. Gross, D. Walb, 1989, Klinische Wochenschrift.

Role of Renal Nerves, Angiotensin II, and Prostaglandins in the Antinatriuretic Response to Acute Hypercapnic Acidosis in the Dog

R. J. Anderson, R. Anderson, W. Henrich, 1982, Circulation research.

Chronic, diagnosis-resistant hypokalaemia.

P. Gross, D. Reimann, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Vasopressin and hyponatremia in renal insufficiency.

W. Rascher, P. Gross, 1986, Contributions to nephrology.

Resumption of peritoneal dialysis after transcutaneous treatment of a peritoneal leakage using fibrin glue.

F. Pistrosch, K. Herbrig, P. Gross, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

CONIVAPTAN, A NOVEL V1A/V2 ANTAGONIST, INCREASED SERUM SODIUM AND EFFECTIVE WATER CLEARANCE IN HYPONATREMIA CLINICAL TRIALS: 590

P. Gross, N. Smith, 2004 .

V2-vasopressin receptor antagonists-mechanism of effect and clinical implications in hyponatraemia.

P. Gross, C. Palm, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Panel recommendations on hyponatremia.

P. Gross, 2014, The American journal of medicine.

CONIVAPTAN, A NOVEL ARGININE VASOPRESSIN ANTAGONIST, PRODUCED AQUARESIS AND INCREASED SERUM SODIUM CONCENTRATION IN PATIENTS WITH EUVOLEMIC OR HYPERVOLEMIC HYPONATREMIA.: 234-T

J. Verbalis, J. Ghali, P. Gross, 2005 .

Tryptophan immunoadsorption strongly reduces proteinuria in recurrent nephrotic syndrome.

J. Passauer, P. Gross, E. Büssemaker, 2001, Nephrology, Dialysis and Transplantation.

Endothelin: what role in acute contrast nephropathy?

P. Gross, E. Büssemaker, 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Correction of hyponatremia.

P. Gross, 2001, Seminars in nephrology.

The treatment of severe hyponatremia.

J. Verbalis, R. Schrier, G. Decaux, 1998, Kidney international. Supplement.

Evaluation of hyponatraemia: is there a rational approach?

J. Hensen, P. Gross, 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Vasopressin and Hyponatremia in Renal Insufficiency1

W. Rascher, P. Gross, 1986 .

Elevated plasma concentration of arginine-vasopressin in renal insufficiency is not caused by nonspecific binding of metabolic breakdown products.

W. Rascher, M. Bald, P. Gross, 1991, Nephron.

Successful treatment due to vacuum seal technique of a severe Scedosporium apiospermum skin infection in a renal transplant recipient.

E. Büssemaker, P. Gross, D. Reimann, 2004, Nephrology, Dialysis and Transplantation.

Hyponatraemia in a neurosurgical patient.

P. Gross, 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

10-Year Evaluation of Adherence and Satisfaction with Information about Tolvaptan in ADPKD: A Single-Center Pilot Study

A. Paliege, C. Hugo, P. Gross, 2021, Patient preference and adherence.

PPA_A_325738 1941..1952

A. Paliege, C. Hugo, P. Gross, 2021 .